- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Dynavax Technologies Corp+ Add to Watchlist
DVAX:US21.7400 USD 0.2400 1.09%
As of 20:10:00 ET on 05/22/2015.
Company Profile for Dynavax Technologies Corp (DVAX)
Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.
Dynavax Technologies Corp
Key Executives for Dynavax Technologies Corp (DVAX)
|Eddie GrayChief Executive Officer||Robert Lee CoffmanSenior VP/Chief Scientific Ofcr|
|David NovackSenior VP:Ops & Quality||Michael S OstrachVP/CFO/Chief Bus Ofcr/Gen Cnsl|
|David L JohnsonVP/Chief Acctg Officer||Robert JanssenVP:Clinical Dev/Chief Medical Ofcr|